@vecgroningen.bsky.social
How do I get to #IVW2026? It is easy, with 100s of flights to Australia daily! Check out #Momondo for flight deals worldwide. While you're here, why not add a trip to New Zealand! vasculitis-melbourne2026.com, Registration opens on 28 March #11daystogo
17.03.2025 22:10 โ ๐ 2 ๐ 3 ๐ฌ 0 ๐ 0Happy to share our latest publication! Here we document the spatial distribution of fibroblast subtypes in relation to vascular remodeling in GCA. Great work by Shuang Xu William Febry Jiemy and Maria Sandovici!
academic.oup.com/rheumatology...
ANZVASC Bluesky account โ๏ธ
22nd Int Vasculitis Workshop website โ๏ธ
vasculitis-melbourne2026.com
All things #vasculitis in Melbourne Feb 2026. Key dates, things to do and promotional tools.
Come for exceptional research, learning and interactions,
And....a great trip to Australia and New Zealand!
Anti-myeloperoxidase IgM B cells in anti-neutrophil cytoplasmic antibody-associated vasculitis
14.02.2025 06:46 โ ๐ 2 ๐ 2 ๐ฌ 0 ๐ 0Does autoreactive IgM complement IgG in ANCA associated vasculitis? Interesting observations by the group of Hans Ulrich Scherer with contributions from the Vasculitis Expertise Center Groningen as part of a collaboration within the Target to B consortium.
www.nature.com/articles/s41...
AI analysis of cliniciansโ notes in medical records helps identify AAV
11.02.2025 05:27 โ ๐ 1 ๐ 1 ๐ฌ 0 ๐ 0Happy 1-year anniversary today @bsky.app!
07.02.2025 03:04 โ ๐ 382 ๐ 29 ๐ฌ 10 ๐ 1New paper alert!
Here, we analyzed monocytes and macrophages across three compartments in PMR patients, circulation, bursa fluid and bursa tissue. Our findings revealed a complex cytokine network that drives the development of pro-inflammatory macrophages.
www.sciencedirect.com/science/arti...
We are excited to announce the upcoming thesis defense of Shuang Xu !
On February 12th 11 am, Shuang Xu aka Lia, will defend her excellent work on fibroblast diversity and function in giant cell arteritis. If you are interested in learning more, here thesis is available here: bit.ly/3EexTtU
Examples like this are why I am optimistic about the huge potential for AI to dramatically improve healthcare and health outcomes.
04.02.2025 03:54 โ ๐ 157 ๐ 13 ๐ฌ 5 ๐ 0Our gut microbiome and its metabolites have key interactions with our immune response to cancer and success from cancer immunotherapy. Nice perspective @jclinical-invest.bsky.social www.jci.org/articles/vie...
03.02.2025 22:11 โ ๐ 480 ๐ 93 ๐ฌ 16 ๐ 3Blood biomarkers in a middle-aged population suggest that SARS-CoV-2 infection is associated with greater brain ฮฒ-amyloid plaque accumulation. The findings published in Nature Medicine suggest that SARS-CoV-2 may increase the risk of future Alzheimerโs disease. #Medsky ๐งช
02.02.2025 21:46 โ ๐ 167 ๐ 71 ๐ฌ 6 ๐ 10DeepSeek's open AI model is giving scientists worldwide the opportunity to train custom reasoning models designed to solve problems in their disciplines.
https://go.nature.com/4hxoRGD
Our op-ed @nytopinion.nytimes.com today addresses the surprising results of recent medical studies that showed A.I. alone outperformed physicians using A.I. W/@rajpurkar.bsky.social
Here is a summary Table, an overview, and a gift link to the op-ed
erictopol.substack.com/p/when-docto...
And it's out! The BIC lab presents our new perspective article on "Immune Control of Brain Physiology" - fresh off the press at
@natrevimmunol.bsky.social
nature.com/articles/s41...
wonderful synergy:
@marikovacs.bsky.social
@amaia-db.bsky.social
and @fakesamir.bsky.social
Our analysis revealed altered expression of key immune molecules on B cells in GPA, with FcฮณRIIB, BTLA, and CD21 linked to disease activity highlighting the intricate immune dysregulation in GPA. Future studies should explore underlying mechanisms and assess their clinical relevance.
31.01.2025 11:52 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0Our paper on deep phenotyping of B cells in PR3-ANCA+ GPA patients is now published!
doi.org/10.1093/cei/...
๐ Join us! ๐
Weโre reaching out to vasculitis patients and clinicians to join us in the Technical Plausibility Testing of an AI Tool, which will take place throughout 2025.
Your expertise and insights can make a difference!
Image
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV-154 in Adults With Glucocorticoid-Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
https://pubmed.ncbi.nlm.nih.gov/39866124
This is the first post from the Vasculitis Expertise Center Groningen on Bluesky! Here, weโll share updates on our research and teaching activities, as well as insights into vasculitis management and pathogenesis. #vasculitis #translational-research #immunology
29.01.2025 14:56 โ ๐ 4 ๐ 0 ๐ฌ 0 ๐ 0